Researchers Identify Key Targets to Improve Maturation of Stem Cell-Derived Beta Cells for Diabetes Treatment
Researchers used a multi-omic, single-cell framework to compare stem cell-derived beta cells (SCβ-cells) to primary human beta cells, identifying key functional and molecular differences. SCβ-cells showed abnormal electrophysiology, immature insulin granules, and altered mitochondrial metabolism despite some exocytotic activity. The findings nominate the SREBP1 cholesterol and lipid homeostasis pathway as a target to improve SCβ-cell maturation, with potential implications for diabetes cell replacement therapy.
A preprint study posted to bioRxiv employed an integrated multi-omic approach—combining patch-clamp electrophysiology with single-cell RNA sequencing (patch-seq), regulatory network inference, and functional phenotyping—to systematically compare stem cell-derived beta-like cells (SCβ-cells) to primary human beta cells. While SCβ-cells exhibited larger sodium and calcium currents and some depolarization-induced exocytosis, they showed low insulin secretion, reduced insulin content, immature insulin granules, and altered mitochondrial morphology. Metabolic profiling further revealed elevated basal respiration, increased proton leak, and diminished glucose-responsive metabolism in SCβ-cells, consistent with incomplete terminal differentiation. Patch-seq analysis linked exocytotic hyperactivity to oxidative phosphorylation and MYC target gene programs, and SCβ-cells expressing higher levels of mature identity markers showed reduced ion channel overactivity. Using network control theory, the researchers identified SREBP1—an endoplasmic reticulum-tethered transcription factor regulating cholesterol and lipid homeostasis—as a key candidate driving the immature state, and demonstrated that inhibiting cholesterol trafficking increased SREBF1 expression and shifted cells toward a more mature beta-like profile.
What's missing
As a preprint, this study has not yet undergone peer review, so its methods and conclusions have not been independently validated. The study does not report whether SREBP1 pathway manipulation improves functional insulin secretion in vivo or in transplantation models, leaving therapeutic translation uncertain. It is also unclear whether the maturation improvements observed are durable or sufficient to reach the functional threshold required for clinical cell replacement therapy.
What different sources said
- bioRxivCenter
Multi-modal comparison of primary and stem cell-derived β-cells nominates targets for maturation
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.